Today: 12 May 2026
Fidelity to Close Eight Canada Funds as Freedom 2045, 2015 Beat Benchmarks in Q4
1 April 2026
2 mins read

Fidelity to Close Eight Canada Funds as Freedom 2045, 2015 Beat Benchmarks in Q4

TORONTO, April 1, 2026, 07:03 EDT

Fidelity Investments Canada ULC plans to wind down eight funds, part of an effort to trim its roster, the firm said Tuesday. Quarterly reports out this week also showed Fidelity’s Freedom 2045 and 2015 retirement funds outperformed their composite benchmarks late in 2025. The Canadian funds on the chopping block have already stopped accepting new investors; most closures are set for around July 24.

This puts holders on the clock: they’ll need to choose whether to switch or cash out before the expected July 24 deadline. The backdrop? Managers are continuing to pare down their offerings. Just a day prior, Invesco Canada announced it will wind up two funds by around May 29, shelving a previously planned transfer of those mandates to CI Global Asset Management. In the U.S. retirement sector, Sway Research founder Chris Brown pointed out that smaller target-date managers still face the “scale advantages held by market leaders.” Newswire

Fidelity is shutting down several Canadian products, including the Fidelity Canadian Monthly High Income ETF and its fund counterpart, as well as the Fidelity Global Monthly High Income ETF and its fund version. Also on the chopping block: Fidelity Long-Term Leaders Currency Neutral Fund and Fidelity Long-Term Leaders Fund. Two corporate-class funds—Fidelity Disruptors Class and Fidelity Disruptive Automation Class—are headed for closure too, though those require securityholder sign-off at virtual meetings penciled in for around June 25. The ETFs themselves won’t leave the Toronto Stock Exchange until after that step.

Fidelity’s latest quarterly reviews put the $24.8 billion Freedom 2045 Fund up 3.70% for the fourth quarter, with a 23.77% advance for 2025. Both figures outpaced the composite benchmark, which posted 3.14% and 21.40%, respectively. As for the $4.3 billion Freedom 2015 Fund, it gained 1.86% over the quarter and 13.19% for the year—topping its benchmark’s 1.69% and 11.90%.

Active asset allocation and stock picking worked in the funds’ favor, Fidelity said. The biggest boost came from a tilt toward non-U.S. equities, as international and emerging-market shares topped U.S. stocks for the quarter. On the domestic side, large-cap strategies managed by Steve Wymer and Matt Fruhan added value. The main drag: Vincent Montemaggiore’s Overseas Fund.

Target-date funds, which gradually move assets from equities into bonds as investors near retirement, continue to dominate the retirement landscape. Morningstar put the market’s 2025 growth at 20.3%, reaching $4.8 trillion. Vanguard, Fidelity, T. Rowe Price, BlackRock, and Capital Group together accounted for 80% of the pie. Analyst Mahi Roy described the space as “highly competitive,” adding, “scale and distribution are key.” Plan Adviser

In its 2025 review, Fidelity said it’s already making changes to the Freedom funds’ glide path—the preset mix of stocks and bonds that shifts toward conservatism as time goes on. The firm is boosting early-career investors’ equity exposure, and for those approaching or in retirement, it’s adding more equities along with inflation-sensitive assets.

The Canadian plan remains in flux. Those two corporate-class funds still face a shareholder vote, and while ETF delistings are anticipated, they haven’t happened yet. Investors holding the affected funds will need to choose between switching or redeeming ahead of the slated July deadline. As of March 18, Fidelity Canada managed $363 billion and said it will issue notices at least 60 days before the expected effective date.

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
NVIDIA Corporation Bets $2 Billion on Marvell as Custom AI Chip Race Heats Up
Previous Story

NVIDIA Corporation Bets $2 Billion on Marvell as Custom AI Chip Race Heats Up

PECO Seeks Another 12.5% Rate Hike. Why Philly Utility Bills Could Rise Again in 2027. (WHYY)
Next Story

PECO Seeks Another 12.5% Rate Hike. Why Philly Utility Bills Could Rise Again in 2027. (WHYY)

Go toTop